RT @CochraneAirways: New #CochraneEvidence: Anti-interleukin-13 and anti-interleukin-4 agents versus placebo, anti-interleukin-5 or anti-im…
RT @CochraneAirways: In particular, the agents appeared to provide greater clinical benefit in patients with higher levels of certain infla…
RT @CochraneUK: Anti‐interleukin‐13 or anti‐interleukin‐4 agents versus placebo, anti‐interleukin‐5 or anti‐immunoglobulin‐E agents, for ch…
RT @ATS_BSHSR: #Anti- #interleukin-13 and #anti- #interleukin-4 agents versus #placebo, #anti- #interleukin-5 or #anti- #immunoglobulin-E a…
#Anti- #interleukin-13 and #anti- #interleukin-4 agents versus #placebo, #anti- #interleukin-5 or #anti- #immunoglobulin-E agents, for people with #asthma https://t.co/nXP6RBexYA https://t.co/Tz1R92lss0
Anti‐interleukin‐13 or anti‐interleukin‐4 agents versus placebo, anti‐interleukin‐5 or anti‐immunoglobulin‐E agents, for children and adults with #asthma - https://t.co/JKAXXnBq6z New @CochraneAirways systematic review.
RT @CochraneAirways: New #CochraneEvidence: Anti-interleukin-13 and anti-interleukin-4 agents versus placebo, anti-interleukin-5 or anti-im…
RT @CochraneAirways: New #CochraneEvidence: Anti-interleukin-13 and anti-interleukin-4 agents versus placebo, anti-interleukin-5 or anti-im…
RT @CochraneAirways: New #CochraneEvidence: Anti-interleukin-13 and anti-interleukin-4 agents versus placebo, anti-interleukin-5 or anti-im…
RT @CochraneAirways: New #CochraneEvidence: Anti-interleukin-13 and anti-interleukin-4 agents versus placebo, anti-interleukin-5 or anti-im…
In particular, the agents appeared to provide greater clinical benefit in patients with higher levels of certain inflammatory biomarkers.” [3/3] https://t.co/F69O7dHLlB
New #CochraneEvidence: Anti-interleukin-13 and anti-interleukin-4 agents versus placebo, anti-interleukin-5 or anti-immunoglobulin-E agents, for people with asthma https://t.co/F69O7dHLlB https://t.co/l8cqlae7AV